Why Canopy Growth (TSX:WEED) Stock Fell 25% in August 2019

Why Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock remains a top pick for cannabis investors.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Shares of Canada’s leading pot stock Canopy Growth (TSX:WEED)(NYSE:CGC) fell 25% in August 2019. Canopy Growth has lost close to $4 billion in market value last month. So, what drove Canopy Growth stock lower?

Canopy’s first-quarter results

Canopy Growth announced its fiscal first quarter of fiscal 2020 (ended in June) results on August 14, 2019. It reported revenue of $90.5 million with adjusted earnings per share (or EPS) of -$0.30 in the first quarter. This was above analyst revenue estimates of $86 million and EPS estimate of -$0.37.

However, Canopy Growth stock fell 14.5% on August 15, as investors were unimpressed with the company’s unadjusted net loss amounting to a massive $1.28 billion. Canopy Growth attributed the loss to its expansion efforts as well as its acquisition of Acreage Holdings.

Earlier this year, Canopy Growth agreed to acquire Acreage for $3.4 billion. Acreage Holdings is a U.S-based vertically integrated cannabis company. Investors were also worried about less than impressive sales in Canopy’s oils and gels business segment, driving its stock lower.

Constellation Brands books huge loss

Canopy Growth stock fell 6% on August 27 after its largest investor, Constellation Brands (NYSE:STZ) expects to book a loss of $54.8 million in the second quarter of fiscal 2020 (ended in August).

Constellation has attributed this loss to its investment in Canopy Growth. The total loss in the six months is expected to be $132 million for Constellation.

Constellation Brands had initially invested $190 million in Canopy Growth back in 2017 for a 10% stake. It has since increased its investments to $4 billion and now holds over 35% in Canopy Growth.

The last month saw several Cannabis stocks lose value. Aurora Cannabis was down 12%, while CannTrust,  and Hexo lost 26% and 6% respectively. The Horizons Marijuana Life Sciences Index ETF fell 13% in August 2019.

What next for Canopy Growth?

Canopy Growth investors have had a few rough months heading into September. The stock has fallen by a significant 54% since April 29, 2019. In July of this year, Canopy Growth’s board of directors ousted its founder and CEO Bruce Linton due to its piling losses.

While Canopy Growth is still booking massive losses, its management expects the firm to reach profitability within the next three to five years. It will continue to grow revenue at a considerable pace.

The total available market is estimated to expand robustly over the next few years and Canopy wants to focus on laying a strong foundation to benefit from this growth.

Canopy Growth wants to develop intellectual property, build brand value, expand to international markets and scale efficiently to grow sales as well as the bottom line.

During the earnings call, company CEO Mark Zekulin stated, “We are fixated on the process of evolving from builders to operators over the remainder of this fiscal year, meaning that as our expansion program comes to a close in Canada, and as new value-add products come to market in Canada, we demonstrate a sustainable, high margin, profitable Canadian business.”

Canopy Growth stock is one of the largest players in the cannabis space. It is trading at an attractive price after the recent pullback. Analysts also remain optimistic about Canopy and have a 12-month average target price of $56.67 which is 80% higher than the current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Great Cannabis Stocks for New Investors

Quality cannabis companies such as Green Thumb can help long-term investors deliver outsized gains in the upcoming decade.

Read more »

A cannabis plant grows.
Cannabis Stocks

Will Canopy Growth Stock Pass $1 in November 2023?

Canopy Growth (TSX:WEED) stock needs to make some major changes if it hopes to get buyers back on board, and…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Canopy Growth Stock a Buy, Sell, or Hold Right Now?

Shares of Canopy Growth are trading 99% below all-time highs. Here's why WEED stock remains a high risk bet, despite…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Happening With Cannabis Stocks in November 2023?

Cannabis stocks have come a long way in the last five years -- they've dropped a long way. What can…

Read more »

Caution, careful
Cannabis Stocks

Buyer Beware: Canopy Growth Stock Is at Risk of a Bigger Drop

Canopy Growth Corp (TSX:WEED) stock has given investors a rough ride. Here's why it could get worse.

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Cannabis Stocks I’d Buy Over Canopy Growth

Two cannabis stocks were second-fiddles to Canopy Growth before but are better buys today.

Read more »